Inhibrx cancer drug drawing interest of Merck and rivals
Summary
Merck (MRK) stock is in focus as the company and its rivals are seeking agreements for a cancer drug from Inhibrx Biosciences (INBX). Read more here.
Description
Merck (MRK) stock is in focus as the company and its rivals are seeking agreements for a cancer drug from Inhibrx Biosciences (INBX). Read more here.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source